Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Xiaojuan Jiao, Ping Peng, Qin Zhang, Yunfeng Shen
Topics & Concepts
MedicineType 2 Diabetes MellitusDiabetic retinopathyGlucagon-like peptide 1 receptorPlaceboInternal medicineDiabetes mellitusPharmacotherapyAgonistRandomized controlled trialMeta-analysisType 2 diabetesRetinopathyGlucagon-like peptide-1ExenatideEndocrinologyReceptorAlternative medicinePathologyDiabetes Treatment and ManagementRetinal Diseases and TreatmentsPancreatic function and diabetes